Loni Philip Tabb

Dr. Loni Philip Tabb

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Health & Place
Verified
Journal Article
Closed access
LTLoni Philip Tabb
Loni Philip Tabb
LMLeslie A. McClure
Leslie A. McClure
HQHarrison Quick
Harrison Quick
JPJonathan Purtle
Jonathan Purtle
ARAna V. Diez Roux
Ana V. Diez Roux

19 March 2022 in Current Environmental Health Reports
Verified
Journal Article
Closed access
PDF file
MBMegan Bragg
Megan Bragg
JCJorge E. Chavarro
Jorge E. Chavarro
GHGhassan Hamra
Ghassan Hamra
JHJaime Hart
Jaime Hart
LTLoni Philip Tabb
Loni Philip Tabb
KLKristen Lyall
Kristen Lyall

21 November 2012 in BMC Public Health
Verified
Journal Article
Open access
PDF file
Tony GrubesicTony Grubesic
Tony Grubesic
AMAlan T Murray
Alan T Murray
WPWilliam Alex Pridemore
William Alex Pridemore
LTLoni Philip Tabb
Loni Philip Tabb
YLYin Liu
Yin Liu
RWRan Wei
Ran Wei
With Pennsylvania currently considering a move away from an Alcohol Beverage Control state to a privatized alcohol distribution system, this study uses a spatial analytical approach to examine potential impacts of privatization on the number and spatial distribution of alcohol outlets in the city of Philadelphia over a long time horizon.


31 January 2017 in Molecular Autism
Verified
Journal Article
Open access
PDF file
BPBo Y. Park
Bo Y. Park
BLBrian K Lee
Brian K Lee
Igor BurstynIgor Burstyn
Igor Burstyn
LTLoni Philip Tabb
Loni Philip Tabb
JKJeff A. Keelan
Jeff A. Keelan
CNCraig J. Newschaffer
Craig J. Newschaffer
Autism spectrum disorder (ASD) affects more than 1% of children in the USA. The male-to-female prevalence ratio of roughly 4:1 in ASD is a well-recognized but poorly understood phenomenon. An explicit focus on potential etiologic pathways consistent with this sex difference, such as those involving prenatal androgen exposure, may help elucidate causes of ASD. Furthermore, the multi-threshold liability model suggests that the genetic mechanisms in females with ASD may be distinct and may modulate ASD risk in families with female ASD in the pedigree. We examined umbilical cord blood from 137 children in the Early Autism Risk Longitudinal Investigation (EARLI) cohort. EARLI is an ASD-enriched risk cohort with all children having an older sibling already diagnosed with ASD. Fetal testosterone (T), androstenedione (A4), and dehyroepiandrosterone (DHEA) levels were measured in cord blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Robust linear regression models were used to determine associations between cord blood androgen levels and 12-month Autism Observation Scales for Infants (AOSI) scores and 36-month Social Responsiveness Scale (SRS) scores adjusting for potential confounders. Increasing androgens were not associated with increasing 12-month AOSI score or 36-month total SRS score in either boys or girls. However, the association between T and autistic traits among subjects with a female older affected sibling was greater at 12 months (test of interaction, P = 0.008) and deficits in reciprocal social behavior at 36 months were also greater (test of interaction, P = 0.006) than in subjects whose older affected sibling was male. While increased prenatal testosterone levels were not associated with autistic traits at 12 or 36 months, our findings of a positive association in infants whose older ASD-affected siblings were female suggests an androgen-related mechanism that may be dependent on, or related to, genetic liability factors present more often in families containing female ASD cases. However, this initial finding, based on a small subgroup of our sample, should be interpreted with considerable caution.

6 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
UBUsama Bilal
Usama Bilal
LTLoni Philip Tabb
Loni Philip Tabb
Sharrelle BarberSharrelle Barber
Sharrelle Barber
ARAna V. Diez Roux
Ana V. Diez Roux
Background: Preliminary evidence has shown inequities in COVID-19 related cases and deaths in the US. Objective: We explored the emergence of spatial inequities in COVID-19 testing, positivity, confirmed cases, and mortality in New York City, Philadelphia, and Chicago during the first six months of the pandemic. Design: Ecological, observational study at the zip code tabulation area (ZCTA) level from March to September 2020. Setting: Chicago, New York City and Philadelphia. Participants: All populated ZCTAs in the three cities. Measures: Outcomes were ZCTA-level COVID-19 testing, positivity, confirmed cases, and mortality cumulatively through the end of September. Predictors were the CDC social vulnerability index and its four domains, obtained from the 2014-2018 American Community Survey. We examined the spatial autocorrelation of COVID-19 outcomes using global and local Moran’s I and estimated associations using spatial conditional autoregressive negative binomial models. Results: We found spatial clusters of high and low positivity, confirmed cases and mortality, co-located with clusters of low and high social vulnerability. We also found evidence for the existence of spatial inequities in testing, positivity, confirmed cases and mortality for the three cities. Specifically, neighborhoods with higher social vulnerability had lower testing rates, higher positivity ratios, confirmed case rates and mortality rates. Limitations: ZCTAs are imperfect and heterogeneous geographical units of analysis. We rely on surveillance data, which may be incomplete. Conclusion: We found spatial inequities in COVID-19 testing, positivity, confirmed cases, and mortality in three large cities of the US. Registration: N/A Funding source: NIH (DP5OD26429) and RWJF (77644)